Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome.
Bilateral adrenalectomy is indicated for the treatment of ACTH-dependent Cushing's syndrome when the tumorous source of ACTH hypersecretion cannot be identified or removed. Potential advantages of laparoscopic over open adrenalectomy include shorter hospitalization, decreased requirement for postoperative analgesia, and decreased postoperative morbidity due to incisional complications. Bilateral laparoscopic adrenalectomy performed for the treatment of ACTH-dependent Cushing's syndrome was attempted in 19 patients at our institution between 1995 and 1998. Conversion to an open procedure was required in three patients. All patients who underwent bilateral laparoscopic adrenalectomy were subsequently followed to assess the outcome of this intervention. Twelve patients with pituitary-dependent Cushing's syndrome and four with ectopic ACTH syndrome underwent successful bilateral laparoscopic adrenalectomy. All patients experienced resolution of the signs and symptoms (e.g. proximal myopathy, hirsutism, and emotional lability) of Cushing's syndrome as well as weight loss, improved glucose tolerance, and improved control of blood pressure. No residual cortisol secretion was detected in the patients. Bilateral laparoscopic adrenalectomy is a safe and effective treatment for Cushing's syndrome when the ACTH-secreting neoplasm cannot be removed.
Vella
A
A
Division of Endocrinology, Metabolism, and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Thompson
G B
GB
Grant
C S
CS
van Heerden
J A
JA
Farley
D R
DR
Young
W F
WF
D000182:ACTH Syndrome, Ectopic / Q000150:complications; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000502:physiology*; D000328:Adult; D003480:Cushing Syndrome / Q000209:etiology* / Q000601:surgery*; D005260:Female; D006801:Humans; D006964:Hyperpituitarism / Q000150:complications; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome
D000324:Adrenocorticotropic Hormone